NEU neuren pharmaceuticals limited

NEU is materially undervalued, page-84

  1. 2,750 Posts.
    lightbulb Created with Sketch. 1051
    'well within their control'? How can this be true when it is FDA that decides these things? I think NEU was surprised that FDA wanted more info before agreeing to similar endpoints to the Ph2. I don't think the vagaries of bureaucracy and human decision making are 'well within their control'
    No - language has been very positive around sales and as noted many times is above the trend line that NEU expected and guided pre-launch The problem has been we jumped out of the gate very fast and growth has since slowed. Acadia are implementing a number of things to reinvigorate growth and reduce dropouts and time will tell if these are working.
    Last edited by nashezz: 11/10/24
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$13.31
Change
0.770(6.14%)
Mkt cap ! $1.655B
Open High Low Value Volume
$12.96 $14.00 $12.91 $19.76M 1.453M

Buyers (Bids)

No. Vol. Price($)
1 3000 $13.30
 

Sellers (Offers)

Price($) Vol. No.
$13.33 3716 1
View Market Depth
Last trade - 16.10pm 26/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.